Internal medicine, Stroke, Atrial fibrillation, Cardiology and Kidney disease are his primary areas of study. As part of his studies on Internal medicine, Alan S. Go often connects relevant areas like Surgery. His research integrates issues of Acute coronary syndrome, Rate ratio, Physical therapy, Heart disease and Pediatrics in his study of Stroke.
His studies in Heart disease integrate themes in fields like Statistics and Heart failure. His Atrial fibrillation research is multidisciplinary, relying on both Aspirin, Framingham Risk Score, Embolism and Antithrombotic. His Kidney disease study combines topics in areas such as Acute kidney injury, Nephrology, Dialysis and Intensive care medicine.
His main research concerns Internal medicine, Cardiology, Kidney disease, Cohort and Atrial fibrillation. Renal function, Heart failure, Cohort study, Hazard ratio and Stroke are the subjects of his Internal medicine studies. His Heart failure study integrates concerns from other disciplines, such as Heart disease and Intensive care medicine.
The various areas that Alan S. Go examines in his Cardiology study include Framingham Risk Score, Surgery and Risk factor. His Kidney disease course of study focuses on Diabetes mellitus and Body mass index. Within one scientific family, Alan S. Go focuses on topics pertaining to Epidemiology under Cohort, and may sometimes address concerns connected to Incidence.
Alan S. Go mostly deals with Internal medicine, Kidney disease, Cohort, Renal function and Heart failure. His study connects Cardiology and Internal medicine. His Kidney disease research is multidisciplinary, incorporating perspectives in Biomarker, Cohort study, Disease, Acute kidney injury and Dialysis.
In his research on the topic of Cohort, Emergency medicine and Peritoneal dialysis is strongly related with Retrospective cohort study. His studies examine the connections between Renal function and genetics, as well as such issues in Proteinuria, with regards to Creatinine and Odds ratio. He works mostly in the field of Atrial fibrillation, limiting it down to topics relating to Stroke and, in certain cases, Myocardial infarction, Oral anticoagulation and Anticoagulant, as a part of the same area of interest.
Alan S. Go mainly focuses on Internal medicine, Kidney disease, Cohort, Renal function and Hazard ratio. Many of his studies on Internal medicine apply to Cardiology as well. His research in Kidney disease intersects with topics in Biomarker, Interquartile range, Cohort study, Diabetes mellitus and Acute kidney injury.
Alan S. Go combines subjects such as Logistic regression, Epidemiology and Retrospective cohort study with his study of Cohort. His Renal function study also includes fields such as
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Heart Disease and Stroke Statistics—2016 Update: A Report From the American Heart Association
Dariush Mozaffarian;Emelia J. Benjamin;Alan S. Go;Donna K. Arnett.
Circulation (2016)
Executive Summary: Heart Disease and Stroke Statistics—2015 Update: A Report From the American Heart Association
Dariush Mozaffarian;Emelia J. Benjamin;Alan S. Go;Donna K. Arnett.
Circulation (2015)
Heart Disease and Stroke Statistics—2011 Update A Report From the American Heart Association
Véronique L. Roger;Alan S. Go;Donald M. Lloyd-Jones;Robert J. Adams.
Circulation (2011)
Executive Summary: Heart Disease and Stroke Statistics—2013 Update A Report From the American Heart Association
Alan S. Go;Dariush Mozaffarian;Véronique L. Roger;Emelia J. Benjamin.
Circulation (2013)
Executive Summary: Heart Disease and Stroke Statistics--2016 Update: A Report From the American Heart Association.
Dariush Mozaffarian;Emelia J. Benjamin;Alan S. Go;Donna K. Arnett.
Circulation (2016)
CHRONIC KIDNEY DISEASE AND THE RISKS OF DEATH, CARDIOVASCULAR EVENTS, AND HOSPITALIZATION
A.S. Go;G.M. Chertow;D. Fan;C.E. McCulloch.
The New England Journal of Medicine (2004)
Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study.
Alan S. Go;Elaine M. Hylek;Kathleen A. Phillips;YuChiao Chang.
JAMA (2001)
Heart Disease and Stroke Statistics—2012 Update A Report From the American Heart Association
Véronique L. Roger;Alan S. Go;Donald M. Lloyd-Jones;Emelia J. Benjamin.
Circulation (2012)
Executive summary: heart disease and stroke statistics--2010 update: a report from the American Heart Association
Donald Lloyd-Jones;Robert J. Adams;Todd M. Brown;Mercedes Carnethon.
Circulation (2010)
Heart Disease and Stroke Statistics—2014 Update A Report From the American Heart Association
Alan S. Go;Dariush Mozaffarian;Veronique Lee Roger;Emelia J. Benjamin.
Circulation (2014)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
University of California, San Francisco
University of Pennsylvania
Harvard University
Tulane University
National Institutes of Health
Stanford University
University of Pennsylvania
Kaiser Permanente
Case Western Reserve University
Duke University
MIT
St Petersburg University
Case Western Reserve University
Korea Advanced Institute of Science and Technology
University of Geneva
University of Oxford
University of Colorado Boulder
University of Bologna
University of Chicago
University of Missouri
UCSF Benioff Children's Hospital
Friedrich Schiller University Jena
University of California, Berkeley
University of Illinois at Urbana-Champaign
New York University
University of Leicester